X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Torrent Pharma with - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

TORRENT PHARMA vs ALKEM LABORATORIES - Comparison Results

TORRENT PHARMA    Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    TORRENT PHARMA ALKEM LABORATORIES TORRENT PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 26.5 - - View Chart
P/BV x 6.5 6.2 104.4% View Chart
Dividend Yield % 3.1 0.7 441.5%  

Financials

 TORRENT PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    TORRENT PHARMA
Mar-16
ALKEM LABORATORIES
Mar-16
TORRENT PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs1,7201,589 108.2%   
Low Rs1,1341,232 92.0%   
Sales per share (Unadj.) Rs394.5417.5 94.5%  
Earnings per share (Unadj.) Rs101.856.3 180.8%  
Cash flow per share (Unadj.) Rs116.364.7 179.8%  
Dividends per share (Unadj.) Rs40.0012.70 315.0%  
Dividend yield (eoy) %2.80.9 311.4%  
Book value per share (Unadj.) Rs200.3292.9 68.4%  
Shares outstanding (eoy) m169.22119.57 141.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.63.4 107.0%   
Avg P/E ratio x14.025.1 55.9%  
P/CF ratio (eoy) x12.321.8 56.3%  
Price / Book Value ratio x7.14.8 148.0%  
Dividend payout %39.322.6 174.2%   
Avg Mkt Cap Rs m241,435168,653 143.2%   
No. of employees `00010.9NA-   
Total wages/salary Rs m8,5599,171 93.3%   
Avg. sales/employee Rs Th6,129.6NM-  
Avg. wages/employee Rs Th785.8NM-  
Avg. net profit/employee Rs Th1,581.3NM-  
INCOME DATA
Net Sales Rs m66,76449,915 133.8%  
Other income Rs m2,1561,645 131.1%   
Total revenues Rs m68,92051,561 133.7%   
Gross profit Rs m27,2048,482 320.7%  
Depreciation Rs m2,4611,006 244.6%   
Interest Rs m1,859671 277.2%   
Profit before tax Rs m25,0418,451 296.3%   
Minority Interest Rs m0-114 0.3%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-1,4030-   
Tax Rs m6,4141,606 399.4%   
Profit after tax Rs m17,2246,731 255.9%  
Gross profit margin %40.717.0 239.8%  
Effective tax rate %25.619.0 134.8%   
Net profit margin %25.813.5 191.3%  
BALANCE SHEET DATA
Current assets Rs m46,62227,062 172.3%   
Current liabilities Rs m32,84315,324 214.3%   
Net working cap to sales %20.623.5 87.8%  
Current ratio x1.41.8 80.4%  
Inventory Days Days7467 111.6%  
Debtors Days Days7941 191.4%  
Net fixed assets Rs m39,02912,610 309.5%   
Share capital Rs m846239 353.9%   
"Free" reserves Rs m31,40034,490 91.0%   
Net worth Rs m33,89035,027 96.8%   
Long term debt Rs m18,6371,212 1,538.2%   
Total assets Rs m90,13654,387 165.7%  
Interest coverage x14.513.6 106.4%   
Debt to equity ratio x0.50 1,589.8%  
Sales to assets ratio x0.70.9 80.7%   
Return on assets %21.213.6 155.6%  
Return on equity %50.819.2 264.5%  
Return on capital %48.524.9 195.3%  
Exports to sales %43.312.9 334.8%   
Imports to sales %6.93.1 222.5%   
Exports (fob) Rs m28,9346,461 447.8%   
Imports (cif) Rs m4,5841,540 297.6%   
Fx inflow Rs m29,1856,563 444.7%   
Fx outflow Rs m6,0213,012 199.9%   
Net fx Rs m23,1653,552 652.2%   
CASH FLOW
From Operations Rs m27,1327,259 373.8%  
From Investments Rs m-7,0141,864 -376.3%  
From Financial Activity Rs m-14,352-9,273 154.8%  
Net Cashflow Rs m5,767-150 -3,844.3%  

Share Holding

Indian Promoters % 71.5 66.9 106.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.0 33.1 21.2%  
FIIs % 12.6 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 8.8 0.0 -  
Shareholders   26,511 68,381 38.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare TORRENT PHARMA With:   PFIZER  ABBOTT INDIA  FRESENIUS KABI ONCO.  WYETH LTD  GSK PHARMA  

Compare TORRENT PHARMA With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Infosys Surges 3% on Buyback News(09:30 am)

Majority of Asian stock indices are higher today as Chinese and Hong Kong shares show gains. The Shanghai Composite is up 0.26% while the Hang Seng is up 0.05%.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

Aug 7, 2017

The data tells us quite a different story from the one the government is trying to project.

Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

Aug 4, 2017

The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

Aug 8, 2017

Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

Signs of Life in the India VIX(Daily Profit Hunter)

Aug 12, 2017

The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

Aug 7, 2017

Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

TORRENT PHARMA SHARE PRICE


Aug 17, 2017 11:41 AM

TRACK TORRENT PHARMA

  • Track your investment in TORRENT PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON TORRENT PHARMA

TORRENT PHARMA 8-QTR ANALYSIS

COMPARE TORRENT PHARMA WITH

MARKET STATS